Neurology Central

Journal watch: Staging Alzheimer’s disease using tau PET and the interaction of amyloid and tau

Wang and colleagues of Washington University, MO, USA, reported that tau imaging has the potential to stage preclinical and clinical Alzheimer’s disease (AD). The research, reported in JAMA Neurology, demonstrated that the binding of tau ligand [18F]-AV-1451 was associated with a battery of AD biomarkers and successfully differentiated AD participants from cognitively normal (CN) participants.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.